Contract Notice Detail

Summary Information

Summary Information
31/3828/2024 
Medicamento Carfilzomib 30 mg Pó sol inj Fr IV 
Tendering Phase
Awarded
31/3828/2024 - Medicamento Carfilzomib 30 mg Pó sol inj Fr IV 
VortalGOV - Acquisition under a Framework Agreement (via Direct Award) 
Lot NameLot Base PriceExpected Duration
C23134 - CARFILZOMIB [30 MG; PÓ SOL INJ; FRS]-5 (Months)

Object of the Contract

Object of the Contract
Supplies Acquisition 
Rua Leão Penedo 8000-386 União das freguesias de Faro (Sé e São Pedro) Faro PORTUGAL  
33600000-6 - Pharmaceutical products
 
 
 

Scheduling

Scheduling
8/1/2024 1:58 PM (UTC +1 hour)
 
9/4/2023 12:00 AM (UTC +1 hour)
 
8/2/2024 5:00 PM (UTC +1 hour)
 

Financial Settings

Financial Settings
No 

Contract Documents

Contract Documents
Document NameDescriptionDoc Classification
31000038282024.xlsx31000038282024.xlsxDownload
convite 258º.pdfconvite 258º.pdfDownload

Object of contract

No 
No 

Legal, economic, financial and technical information

No 

Questionnaire

Questionnaire
1
Lot Title
C23134 - CARFILZOMIB [30 MG; PÓ SOL INJ; FRS]

1.1   Bill of Quantities  *  
This price list has extra requirements. Make sure everything is completed, under each article line.

Item Code Description Quantity Unit
C23134 CARFILZOMIB [30 MG; PÓ SOL INJ; FRS] 20,000000 UN
Buyer Comment: 502942959 | Amgen Biofarmacêutica, Lda. | CPA:2023491/103/0262 | NºAIM:5688312;
TOTAL (The amounts shown do not include VAT)

Evaluation

Evaluation
Vision

Avaliação

Definir modelo de avaliação
Modalidade de avaliação
Método de Avaliação
Divulgar critérios de avaliação

Critérios da Avaliação

1 - C23134 - CARFILZOMIB [30 MG; PÓ SOL INJ; FRS]

Critérios da Avaliação

Descrição
Tipo de Fator
Peso (%)
1.PricePreço100%

Normas de desempate

Definir normas de desempate?

Public Messages

Public Messages
TypeReferenceSubjectDate
No items found...